ARTICLE | Company News
Cobra Bio, Replikun Biotech Pty Ltd. deal
February 6, 2006 8:00 AM UTC
CBF will manufacture a cell line that produces Replikun's KUN-GMCSF cancer gene therapy. KUN-GMCSF is based on Replikun's Kunrep vectors, which are derived from the Kunjin virus. ...